IBSRELA

knight therapeutics inc.🇨🇦 Health Canada

Approval Id: 22d0bc944bfca2ff
Drug Approval Canada Name: IBSRELA
Product Name: IBSRELA
Status: Marketed
Status Date: 2020-11-23
Original Market Date: 2020-11-23
Din: 02498049
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 40:18.19
Atc Original: A06AX08 TENAPANOR
Atc Name: a 06 ax 08
Aig Number: 0162174001
Company Name: knight therapeutics inc.
Company Address: 1055, 3400 De Maisonneuve Blvd W, Montreal, Quebec, Canada, H3Z 3B8

TENAPANOR (TENAPANOR HYDROCHLORIDE)

50 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

22d0bc944bfca2ff

Type

Standard